Elevance Health, Inc. (ELV)
(Delayed Data from NYSE)
$313.71 USD
-2.06 (-0.65%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $313.75 +0.04 (0.01%) 6:14 PM ET
5-Strong Sell of 5 5
A Value F Growth F Momentum D VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
ELV 313.71 -2.06(-0.65%)
Will ELV be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for ELV based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ELV
CVS Health Steps Up to Bolster Oak Street as Cost Pressures Mount
Arista Networks and Elevance Health have been highlighted as Zacks Bull and Bear of the Day
ELV: What are Zacks experts saying now?
Zacks Private Portfolio Services
Bear of the Day: Elevance Health (ELV)
New Strong Sell Stocks for September 15th
Elevance Health Shrinks to Grow Stronger: From Part D to Plan B?
Other News for ELV
ELV Crossed Above 20 Day Moving Average on September 18
Tracking William Nygren's Harris Associates Portfolio - Q2 2025 Update
20 Day Moving Average Resistance appears for ELV after 0.49% move
Obamacare tax credits could expand budget deficit by $350B if extended, CBO says
U.S. health insurers pledge continuing coverage of COVID shots ahead of ACIP meeting